News

InflaRx Izicopan Shows Low Reactive Metabolite Formation in Liver Safety Study

2 min

MacroGenics Expands ZYNYZ Royalty Agreement with Sagard Healthcare Partners for Cancer Drug

2 min

Akebia Therapeutics Vadadustat Shows Significant Mortality Reduction in New Kidney Disease Analysis

2 min

InflaRx Reports Favorable Safety Profile for Izicopan in Liver Metabolism Study

2 min

Celcuity's Gedatolisib Meets Phase 3 Primary Endpoint in PIK3CA Mutant Cancer Trial

Oncology · 3 min

FDA Approves LANGLARA Interchangeable Biosimilar to Lantus Insulin - Lannett Company Enters Diabetes Market

FDA · Diabetes/Endocrinology · 4 min

FDA Approves Incyte's Jakafi XR Extended-Release Tablets for Myelofibrosis and Blood Disorders

FDA · Hematology/Oncology · 3 min

Arvinas VEPPANU (Vepdegestrant) Receives FDA Approval as First PROTAC Drug for ESR1-Mutated Breast Cancer

FDA · Oncology - Advanced Breast Cancer · 3 min

Excipient World Conference: Key Highlights and Industry Trends

general · 8 min

APHL 2026 Annual Meeting: Day 1 Highlights

general · 3 min

APHL 2026: Day 1 Highlights and Key Takeaways

general · 3 min

THMA Pharmacy Growth Priorities 2026: Key Insights for CPOs

cardiology · 8 min